Chien-Wei Peng

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Antiretroviral Therapy

Hepatitis B Virus

Prognostic Factors

Ejection Fraction

Top Venues

Alimentary pharmacology & therapeutics

Journal of gastroenterology and hepatology

The Journal of antimicrobial chemotherapy

Journal of viral hepatitis

This page only lists publications with an associated author ORCID identifier.

Publications

Yen-Chun Liu, Wen-Juei Jeng, Chien-Wei Peng, Rong-Nan Chien, Yun-Fan Liaw
Higher end-of-treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg-negative chronic hepatitis B patients stopping antivirals. Alimentary pharmacology & therapeutics 59 (6) (2024)
Yen-Chun Liu, Wen-Juei Jeng, Chien-Wei Peng, Rong-Nan Chien, Yun-Fan Liaw
Higher end-of-treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg-negative chronic hepatitis B patients stopping antivirals. Alimentary pharmacology & therapeutics 59 (6) (2024)
Yen-Chun Liu, Wen-Juei Jeng, Chien-Wei Peng, Rong-Nan Chien, Yun-Fan Liaw
Higher end-of-treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg-negative chronic hepatitis B patients stopping antivirals. Alimentary pharmacology & therapeutics (2024)
Yen-Chun Liu, Wen-Juei Jeng, Chien-Wei Peng, Rong-Nan Chien, Yun-Fan Liaw
Higher end-of-treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg-negative chronic hepatitis B patients stopping antivirals. Alimentary pharmacology & therapeutics (2024)
Yen-Chun Liu, Wen-Juei Jeng, Chien-Wei Peng, Rong-Nan Chien, Yun-Fan Liaw
Higher end-of-treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg-negative chronic hepatitis B patients stopping antivirals. Alimentary pharmacology & therapeutics 59 (6) (2024)
Chien-Wei Peng, Wen-Juei Jeng, Hwai-I Yang, Yen-Chun Liu, Rong-Nan Chien, Yun-Fan Liaw
A switch from tenofovir to entecavir prior to hepatitis B treatment cessation is associated with a reduced risk of off-therapy relapse: An observational study. Journal of gastroenterology and hepatology 37 (11) (2022)
Wen-Juei Jeng, Yen-Chun Liu, Chien-Wei Peng, Rong-Nan Chien, Yun-Fan Liaw
Highly significant differences in HBsAg kinetics among patients with two types of hepatitis B flare, with and without retreatment. The Journal of antimicrobial chemotherapy (2021)
Chien-Wei Peng, Wen-Juei Jeng, Rong-Nan Chien, Yun-Fan Liaw
The impact of hepatitis flare on HBeAg loss was effective mainly in the first year of Nucleot(s)ide therapy in chronic hepatitis B. Journal of viral hepatitis 28 (3) (2020)